Clinical Trials Directory

Trials / Completed

CompletedNCT01807455

An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the efficacy and safety of Restylane Vital Lidocaine when acne scars are treated

Conditions

Interventions

TypeNameDescription
DEVICERestylane Vital Lidocaine

Timeline

Start date
2013-04-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-03-08
Last updated
2022-08-26
Results posted
2016-01-25

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01807455. Inclusion in this directory is not an endorsement.

An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine (NCT01807455) · Clinical Trials Directory